title: Acquired Tolerance to Ivermectin and Moxidectin after Drug Selection Pressure in the Nematode Caenorhabditis elegans.
abstract: Ivermectin and moxidectin are the most widely administered anthelmintic macrocyclic lactones (MLs) to treat human and animal nematode infections. Their widespread and frequent use has led to a high level of resistance to these drugs. Although they have the same mode of action, differences in terms of selection for drug resistance have been reported. Our objective was to study and compare changes occurring upon ivermectin or moxidectin selection in the model nematode Caenorhabditis elegans C. elegans worms were submitted to stepwise exposure to increasing doses of moxidectin. The sensitivity of moxidectin-selected worms to MLs was determined in a larval development assay and compared with those of wild-type and ivermectin-selected strains. Selection with either ivermectin or moxidectin led to acquired tolerance to ivermectin, moxidectin, and eprinomectin. Importantly, moxidectin was the most potent ML in both ivermectin- and moxidectin-selected strains. Interestingly, this order of potency was also observed in a resistant Haemonchus contortus isolate. In addition, ivermectin- and moxidectin-selected strains displayed constitutive overexpression of several genes involved in xenobiotic metabolism and transport. Moreover, verapamil potentiated sensitivity to ivermectin and moxidectin, demonstrating that ABC transporters play a role in ML sensitivity in ML-selected C. elegans strains. Finally, both ivermectin- and moxidectin-selected strains displayed a dye-filling-defective phenotype. Overall, this work demonstrated that selection with ivermectin or moxidectin led to cross-resistance to several MLs in nematodes and that the induction of detoxification systems and defects in the integrity of amphidial neurons are two mechanisms that appear to affect the responsiveness of worms to both ivermectin and moxidectin.
authors.affiliation: Toxalim, Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, Toulouse, France cecile.menez@toulouse.inra.fr.
authors.forename: Cécile
authors.initials: C
authors.lastname: Ménez
authors.affiliation: Toxalim, Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, Toulouse, France.
authors.forename: Mélanie
authors.initials: M
authors.lastname: Alberich
authors.affiliation: Toxalim, Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, Toulouse, France.
authors.forename: Dalia
authors.initials: D
authors.lastname: Kansoh
authors.affiliation: INRA, UMR 1282 Infectiology and Public Health, Nouzilly, France Université François Rabelais de Tours, Tours, France.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Blanchard
authors.affiliation: Toxalim, Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, Toulouse, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Lespine
mesh_terms: D000818:Animals; D017173:Caenorhabditis elegans / Q000187:drug effects*; D004351:Drug Resistance / Q000187:drug effects; D006189:Haemonchus / Q000187:drug effects; D007559:Ivermectin / Q000031:analogs & derivatives / Q000494:pharmacology*; D007783:Lactones / Q000494:pharmacology; D007814:Larva / Q000187:drug effects; D018942:Macrolides / Q000494:pharmacology*; D010641:Phenotype; D014700:Verapamil / Q000494:pharmacology
chemical_list: D007783:Lactones; D018942:Macrolides; D007559:Ivermectin; C101434:eprinomectin; D014700:Verapamil; C027837:moxidectin